CanBiocin Inc. is a privately held R&D company that specializes on development of innovative and socially beneficial lactic acid bacteria-based products.
CanBiocin was formed in 1998 as a University of Alberta spin-off company to commercialize novel technologies developed from research conducted by professors Michael Stiles, Lynn McMullen and John Vederas. The technologies are based on the application of lactic acid bacteria (LAB) for food safety and to enhance animal and human health.